Search

Background: Pruritus is prevalent in psoriasis but still many features of pruritus, its response to therapy and its burden in psoriasis remain to be better characterized., Objective: To investigate characteristics and burden of pruritus in an international cohort of patients with psoriasis., Methods: This cross-sectional study included a total of 634 patients and 246 controls from Germany, Poland and Russia. Physicians examined and interviewed participants, recording clinical characteristics, such as severity, therapy and localization of psoriatic lesions. Participants filled out self-reported questionnaires including questions on pruritus severity and impact, characteristics, and response to therapy, and quality of life (QoL). Localization patterns of pruritus and skin lesions were visualized using body heat maps., Results: Most patients (82%) experienced pruritus throughout their disease, and 75% had current pruritus. The majority of patients (64%) perceived pure pruritus, and those who reported additional painful and/or burning sensations (36%) reported overall stronger pruritus. The scalp was the most frequently reported localization of pruritus, even in the absence of skin lesions. Body surface area (BSA) of pruritus was not linked to pruritus intensity, but to BSA of psoriatic lesions (rho = 0.278; P < 0.001). One third of patients (31%) reported impaired sex-life, and 4% had suicidal ideations due to pruritus. In up to one third of patients, psoriasis therapies had little or no effect on pruritus. The only therapeutic option offered to some of these patients were antihistamines, which appeared to be effective in most cases., Conclusion: Pruritus is highly prevalent in psoriasis and is linked to a significant burden. Current psoriasis therapies are frequently insufficient to control pruritus. Managing psoriasis should include the assessment and control of itch. Efficient antipruritic therapies should be developed and be made available for patients with psoriasis., (© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.)

Background: Sleep, which is crucial for restoring of physiological functions and health, is reportedly impaired in psoriasis. The role of different potential sleep confounding factors, including detailed pruritus characteristics, and the complex interplay between psychological variables (anxiety and depression), pruritus and sleep disturbance in psoriasis remain insufficiently investigated., Objectives: To investigate sleep characteristics and to identify clinical, demographic and psychological factors associated with sleep disturbance in psoriasis., Methods: This cross-sectional study included 334 psoriasis patients (response rate 86%) and 126 control subjects (response rate 82%). Measures included sleep quality [Pittsburgh Sleep Quality Index (PSQI)], psoriasis severity, pruritus characteristics, including average pruritus intensity [visual analogue scale (VAS)], severity of comorbidities, anxiety and depression (Hospital Anxiety and Depression Scale - HADS) and quality of life (Dermatology Life Quality Index - DLQI, and Short Form 12 - SF12)., Results: Fifty-nine per cent of patients and 34% of control subjects (P < 0.001) suffered from sleep disturbance (PSQI > 5). Patients slept 1 h less than control subjects (median 6 vs. 7 h, P < 0.001). Patients without pruritus had less impaired sleep (global PSQI) than patients with strong (P < 0.001) and very strong pruritus (P < 0.001). Anxiety (HADS-A) and depression (HADS-D) levels were the strongest predictors of sleep impairment, followed by pruritus exacerbation at night, age, female sex, pruritus exacerbation in the morning, average pruritus intensity (VAS), diagnosed depression and gastroesophageal reflux disease, altogether explaining 32%-37% of the variance in global sleep quality. Both anxiety (HADS-A) and depression (HADS-D) were significant mediators explaining the association between pruritus intensity (VAS) and sleep impairment in 42% and 37% respectively., Conclusions: Sleep disturbance in patients with psoriasis is highly prevalent. Patients with psoriasis should be assessed for sleep impairment, pruritus, anxiety and depression. Reduction in pruritus should be considered as an important therapeutic goal, along with therapies aimed at reducing anxiety and depression., (© 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.)

Background: The long-term cardiovascular effects of Coronavirus disease-2019 (COVID-19) are not yet well known. Myocardial performance index (MPI) is a non-invasive, inexpensive and reproducible echocardiographic parameter that reflects systolic and diastolic cardiac functions. The aim of the study was to compare MPI with a healthy control group in patients with mild or moderate COVID-19 infection who subsequently had unexplained cardiac symptoms., Methods: The study included 200 patients aged 18-70 years who were diagnosed with COVID-19 infection at least 2 months ago and defined cardiac symptoms in their follow-up. Patients with mild or moderate symptoms, no history of hospitalization, and no other pathology that could explain cardiac symptoms were included in the study. As the control group, 182 healthy volunteers without COVID-19 were evaluated. Echocardiographic examination was performed on the entire study group. Isovolumetric contraction time (IVCT), isovolumetric relaxation time (IVRT), and ejection time (ET) were measured by tissue Doppler imaging. MPI was calculated with the IVCT+IVRT/ET formula., Results: The mean age of the study group was 44.24 ± 13.49 years. In the patient group the MPI was significantly higher (.50 ± .11 vs .46 ± .07, p < .001), IVRT was longer (69.67 ± 15.43 vs 65.94 ± 12.03 ms, p = . 008), and ET was shorter (271.09 ± 36.61 vs 271.09 ± 36.61 ms, p = .028). IVCT was similar between groups (63.87 ± 13.66 vs. 63.21 ± 10.77 ms, p = .66). Mitral E and mitral A wave, E', A', and E/A were similar in both groups., Conclusions: Our study showed that conventional diastolic function parameters were not affected in patients who survived COVID-19 with mild symptoms but had symptoms in the long term. However, MPI measurements showed left ventricular dysfunction. To our knowledge, this is the first echocardiographic follow-up study to evaluate left ventricular systolic and diastolic functions with MPI in COVID-19 patients. We think that when cardiac involvement assessment is required in patients who have survived COVID-19, MPI should be measured alongside other echocardiographic measurements., (© 2022 Wiley Periodicals LLC.)

In the title salt, C(12)H(18)NO(+)·Cl(-), N-H⋯Cl inter-actions between the free chloride anions and the organic cations connect the mol-ecules into hydrogen-bond dimers, forming a R(2) (2)(8) motif. The dimers are linked by C-H⋯O hydrogen bonds into chains extending along [301]. The carbonyl group is co-planar with the phenyl ring [C-C-C=O torsion angle = -3.3 (7)°]. The side chain has an E conformation.

In the title compound, C(13)H(20)NO(+)·Cl(-), the protonated amino N atom is hydrogen bonded to the chloride anion. N-H⋯Cl hydrogen bonds link the anions and cations into dimers, which are connected by C-H⋯O hydrogen bonds, forming supra-molecular chains extending along [100].

The asymmetric unit of the title compound, C(8)H(8)N(2)O(2), comprises two independent mol-ecules in both of which, all non-H atoms lie in a common plane (r.m.s. deviation = 0.014 and 0.017 Å). In the crystal, N-H⋯O hydrogen bonds connect the mol-ecules into zigzag chains running along [10-1]. Weak C-H⋯O inter-actions connect the chains into an infinite network.

The crystal structure of the title compound, C(12)H(17)BrNO(+)·Cl(-), is stabilized by N-H⋯Cl and C-H⋯O hydrogen bonds, forming a three-dimensional network. The inter-actions framework is completed by C-H⋯π contacts between a methyl-ene group and the benzene ring of a symmetry-related mol-ecule.

In the crystal structure of the polymeric title compound, {[Pb(C(9)H(9)O(2))(2)(C(6)H(6)N(2)O)]·H(2)O}(n), the six-coordinate Pb(II) ion is chelated by two 4-ethyl-benzoate (PEB) anions and is bridged by two nicotinamide (NA) ligands, forming a polymeric chain running along the b axis. The carboxyl-ate groups of the PEB ions are twisted away from the attached benzene rings by 4.0 (6) and 13.3 (5)°. The two benzene rings of the PEB ions bonded to the same metal ion are oriented at a dihedral angle of 87.4 (3)°. In the polymeric chain, the NA ligand is linked to one of the carboxyl-ate groups via N-H⋯O hydrogen bonding. In the crystal, adjacent polymeric chains inter-act via N-H⋯O and weak C-H⋯O hydrogen bonds; and the lattice water mol-ecule links with the polymeric chains via N-H⋯O and O-H⋯O hydrogen bonding. π-π stacking between the benzene and the pyridine rings [centroid-centroid distance = 3.805 (5) Å] and weak C-H⋯π inter-actions are also observed in the crystal structure.

In the title compound, C(26)H(25)Cl(2)NO(2), the piperidine ring adopts a chair conformation with a cis configuration of the carbonyl and hy-droxy substituents. The dihedral angle between the aromatic rings of the chloro-benzene groups is 24.3 (2)°. The phenyl ring forms dihedral angles of 59.4 (3) and 44.1 (3)° with the benzene rings. In the crystal, mol-ecules are linked by inter-molecular O-H⋯N and C-H⋯O hydrogen bonds and C-H⋯π inter-actions into layers parallel to the bc plane.

In the tetra-hydro-isoindole moiety of the title compound, C(17)H(17)NO(3)S, the six-membered ring assumes a boat configuration and the -S=O group bridges the prow and stern of the boat. The phenyl ring is oriented at a dihedral angle of 83.2 (1)° with respect to the pyrrole ring. In the crystal, inter-molecular C-H⋯O hydrogen bonds link the mol-ecules into a three-dimensional network. A weak C-H⋯π inter-action involving the phenyl ring is also found. The crystal studied was an inversion twin.

Rationale: Due to the increase of new cancer cases, our chemotherapy compounding unit must face with ever-growing production needs. To support this increasing workload, we decided to anticipate the preparation of several anti-cancer drugs., Aims and Objectives: To help us in the decision making, we needed a modern tool able to combine several criteria for selecting appropriate medications for an anticipated preparation. The aim of this study was to assess the decision-making software, FabAct(®) (Version 1.0)., Methods: FabAct(®) ranked all of the anti-cancer drugs used in our chemotherapy compounding unit according to price, chemical stability, compounding difficulties, dosage and production per year. Then, we started to anticipate currently the preparation of four medications and conducted a follow-up of destroyed preparations between January and May 2007. We tried to identify the destruction causes and calculated the time saved for the patients and for the pharmacy technicians., Results: According to the decision-making software, the first four drugs for an anticipated preparation were: fluorouracil, cisplatin, carboplatin and paclitaxel. A total of 3913 (50.2%) anticipated preparations were performed and among those, 470 (12%) were destroyed. The main cause of destruction was due to the preparation expiration. Finally, the mean waiting time per patient was reduced from 118 minutes to 68 minutes after the application of the anticipated model., Conclusion: According to this 5-month follow-up, FabAct(®) helped us to select appropriate anti-cancer drugs to anticipate the compounding. Most of the anticipated preparations were administrated to patients and the patient waiting time was significantly reduced., (© 2010 Blackwell Publishing Ltd.)

The mol-ecule of the title compound, C(26)H(26)Br(4)O(6), is located around a crystallographic inversion center. The dihedral angle between the central benzene ring and the outer benzene ring is 89.26 (1)°.

In the title mol-ecule, C(16)H(15)N(3), the indole ring system is planar within 0.021 (3) Å and the phenyl ring is inclined to this plane by 17.32 (14)°. π-π contacts involving the pyrrole rings of inversion-related indole units [centroid-centroid distance = 3.5187 (17) Å] stabilize the crystal structure.

The title compound, C(20)H(24)N(2)O(2)S(2), consists of a tetra-cyclic ring system containing an azocino skeleton with ethyl, dithiol-ane and methoxy-methyl groups as substituents. The benzene and five-membered rings are nearly coplanar, with a dihedral angle of 2.78 (11)°. The dithiol-ane ring adopts an envelope conformation. In the crystal structure, inter-molecular C-H⋯O hydrogen bonds link the mol-ecules into chains nearly parallel to the c axis. Two C-H⋯π inter-actions are also present.

In the title compound, C(19)H(18)N(4)O(2), the 1,8-naphthyridine ring system is essentially planar [r.m.s. deviation = 0.011 (3) Å]. The dihedral angle between the naphthyridine ring system and the phenyl ring is 28.95 (7)°. The carbohydrazide H atom is involved in an intra-molecular N-H⋯O hydrogen bond, forming a six-membered hydrogen-bonded ring. In the crystal, the mol-ecules arrange themselves into centrosymmetric dimers by means of inter-molecular C-H⋯O hydrogen bonds.

In the title Schiff base, C(21)H(25)F(2)NO, the dihedral angle between the aromatic rings is 27.90(5)° and an intramolecular O-H⋯N hydrogen bond occurs. In the crystal, the molecules are linked by C-H⋯O, C-H⋯N and C-H⋯F interactions.

In the title compound, C(18)H(10)N(4), the pyrazine ring is oriented at dihedral angles of 48.08 (7) and 44.80 (7)° with respect to the phenyl rings, while the dihedral angle between the phenyl rings is 49.47 (7)°. In the crystal structure, weak π-π contacts between pyrazine and phenyl rings [centroid-centroid distance = 3.813 (1) Å] may stabilize the structure.

In the crystal structure of the title compound, C(19)H(18)N(4)O(3), the fused-ring system is essentially planar [maximum deviation is 0.031 (2) Å] while the dihedral angle between the ring system and the benzene ring is 12.64 (6)°.The carbohydrazide H atom is involved in an intra-molecular N-H⋯O hydrogen bond, forming a six-membered hydrogen-bonded ring. The mol-ecules arrange themselves into centrosymmetric dimers by means of inter-molecular O-H⋯O hydrogen bonds.

In the crystal structure of the title Co(II) complex, [Co(C(8)H(5)O(3))(2)(C(10)H(14)N(2)O)(2)(H(2)O)(2)], the metal centre is located on an inversion center and is coordinated by two 4-formyl-benzoate (FOB), two diethyl-nicotinamide (DENA) ligands and two water mol-ecules in a slightly distorted CoO(4)N(2) octa-hedral geometry. In the crystal structure, O-H⋯O hydrogen bonds link the mol-ecules into infinite chains. π-π contacts between the parallel pyridine rings of neighboring DENA ligands [centroid-centroid distance = 3.652 (3) Å] further stabilize the crystal structure.

The title complex, [Co(C(6)H(6)N(2)O)(2)(H(2)O)(4)](C(7)H(4)FO(2))(2), contains one Co(II) atom (site symmetry ), two monodentate nicotin-amide (NA) ligands, four coordinated water mol-ecules and two 2-fluoro-benzoate (FB) anions. The four O atoms in the equatorial plane around the Co atom form a slightly distorted square-planar arrangement, while the slightly distorted octa-hedral coordination is completed by the two N atoms of the NA ligands in the axial positions. The dihedral angle between the carboxyl group and the adjacent benzene ring is 29.8 (3)°, while the pyridine and benzene rings are oriented at a dihedral angle of 7.97 (12)°. In the crystal structure, mol-ecules are linked by O-H⋯O, N-H⋯O and N-H⋯F hydrogen bonds, forming an infinite three-dimensional network. π-π Contacts between the pyridine and benzene rings [centroid-centroid distance = 3.673 (3) Å] may further stabilize the crystal structure.

The title compound, [Mn(C(8)H(5)O(3))(2)(C(10)H(14)N(2)O)(2)(H(2)O)(2)], contains one Mn(II) atom lying on an inversion centre, two 4-formyl-benzoate and two diethyl-nicotinamide ligands and two coordinated water mol-ecules. All ligands are monodentate. The four O atoms around the Mn atom form a slightly distorted equatorial plane, while the distorted octa-hedral coordination is completed by the two N atoms in the axial positions. An intra-molecular O-H⋯O hydrogen bond occurs in the complex. In the crystal structure, O-H⋯O hydrogen bonds link the mol-ecules through an R(2) (2)(16) ring motif, forming a one-dimensional chain along the a axis. The π-π contact between the pyridyl rings [centroid-centroid distance = 3.629 (2) Å] may further stabilize the structure.

In the title centrosymmetric mononuclear Ni(II) compound, [Ni(C(8)H(5)O(3))(2)(C(10)H(14)N(2)O)(2)(H(2)O)(2)], the central Ni(II) atom is coordinated by two O atoms from two 4-formyl-benzoate (FOB) ligands, two O atoms from two water mol-ecules and two N atoms from two diethyl-nicotinamide (DENA) ligands. The coordination geometry is slightly distorted octa-hedral, with four O atoms in the equatorial plane and two N atoms in axial positions. Intra-molecular O-H⋯O hydrogen bonds are observed. In the crystal structure, mol-ecules are linked into chains along the a axis by inter-molecular O-H⋯O hydrogen bonds. The structure is further stabilized by π-π inter-actions between the pyridine rings of DENA units, with a centroid-centroid distance of 3.668 (2) Å.

The title compound, C(16)H(20)Cl(2)O(8), contains a central bicyclo-[2.2.2]octane skeleton with slightly twisted conformation. In this structure, the C-C bond lengths are in the range 1.525 (2)-1.552 (2) Å. Two sides of this skeleton have cis,cis acet-oxy substituents and the Cl atoms have a trans arrangement. An extensive network of weak C-H⋯O interactions stabilizes the crystal structure.

The title compound, C(12)H(12)Cl(2)O(2), has a bicyclic skeleton containing cyclo-hexene and benzene fragments. The cyclo-hexene ring adopts a half-chair conformation with displacements of two atoms out of the least-squares plane of 0.311 (2) and -0.336 (2) Å. The Cl atoms are trans-positioned.

In the title compound, C(24)H(28)N(2)O(3)S, the pendant methyl C atom bonded to the cyclo-hexane ring is disordered over two sites in a 0.580 (11):0.420 (11) ratio. The cyclo-hexane ring adopts a distorted chair conformation while the thia-zolidine ring has an envelope conformation. The two phenyl rings make a dihedral angle of 71.8 (2)° with each other. The conformation is stabilized by an intra-molecular N-H⋯O hydrogen bond. In the crystal structure, an inter-molecular hydrogen bond O-H⋯O occurs.

In the title thio-semicarbazone derivative, C(9)H(10)N(4)OS·H(2)O, intra-molecular N-H⋯N hydrogen bonds result in the formation of two nearly coplanar five- and six-membered rings, which are also almost coplanar with the adjacent phenyl ring. The oxime group has an E configuration and is involved in inter-molecular O-H⋯O hydrogen bonding as a donor. In the crystal structure, intra-molecular O-H⋯S and N-H⋯N and inter-molecular O-H⋯O and N-H⋯S hydrogen bonds generate edge-fused R(2) (2)(8) and R(4) (1)(11) ring motifs. The hydrogen-bonded motifs are linked to each other to form a three-dimensional supra-molecular network.

1. It is known that stress causes disruption of homeostasis and an imbalanced anti-oxidant status in several organs. The aim of the present study was to determine the effects of three stress models on protein oxidation, lipid peroxidation and anti-oxidant enzyme activities in the liver, kidney and heart, and to investigate the relationship between corticosterone and some oxidative stress parameters. In addition, we investigated the most effective stress model for each parameter in each tissue. 2. Thirty-six male Wistar rats (aged 3 months old, weighing 220 +/- 20 g) were divided randomly into four groups of nine rats each: control (C), immobilization stress (IS), cold stress (CS), and immobilization-cold stress (ICS). 3. Results showed that corticosterone levels were increased in all stress groups. Levels of protein carbonyl (PC), conjugated dienes (CD) and thiobarbituric acid-reactive substances (TBARS) were increased, whereas reduced glutathione (GSH) levels were decreased in all tissues of all stress groups. Copper, zinc-superoxide dismutase (Cu,Zn-SOD) activities were increased in the liver and kidney of all stress groups, but were decreased in heart of the IS and CS groups. Catalase (CAT) activities were increased in liver of the CS group and in kidney and heart of all stress groups, but were decreased in liver of the IS and ICS groups. Selenium-dependent glutathione peroxidase (Se-GSH-Px) activities were increased in liver of the CS and ICS groups and in heart of all stress groups, but were decreased in kidney of the IS group. Also, Se-GSH-Px activity levels remained unchanged in liver of the IS group and in kidney of the CS and ICS groups. The increased CAT activity and unchanged Se-GSH-Px activity observed in kidney suggest that H2O2 may be primarily scavenged by CAT. 4. The strong correlations between corticosterone and oxidative damage markers (e.g. protein oxidation, lipid peroxidation and GSH levels) suggest a relationship between these parameters. Liver was affected most by the CS model, whereas kidney and heart were affected most by ICS model. Stress-induced changes in the activities of anti-oxidant enzymes and GSH levels were found to be tissue- and enzyme-specific. In conclusion, results of the present study suggest that each stress model affects the different organ tissues in different ways.

In the title compound, C(16)H(20)Cl(2)O(8), the bicyclic system contains a central non-planar cyclohexane ring which is fused to a cyclobutane moiety. The cyclohexane ring has a chair conformation and the whole system adopts a syn conformation. The structure provides information on the stereochemical course of the chlorination, photo-oxidation and hydroxylation steps of the reaction.

Molecules of the title compound (alternative name p-methoxybenzaldehyde 2-pyridylhydrazone), C(13)H(13)N(3)O, adopt an E configuration about the azomethine C=N double bond. Molecules are almost planar, the dihedral angle between the pyridine and methoxyphenyl rings being only 6.19 (12) degrees. Pairwise N-H.N hydrogen bonds [R(2)(2)(8) in graph-set notation] link centrosymmetrically related molecules into discrete pairs.

The asymmetric unit of the title compound, [Pt(C(25)H(22)P(2))(C(27)H(26)P(2))]Br(2) or [Pt(dppm)(dppp)]Br(2), where dppm is bis(diphenylphosphino)methane and dppp is 1,3-bis(diphenylphosphino)propane, consists of a discrete [Pt(dppm)(dppp)](2+) cation and two Br(-) anions at van der Waals distances. This is the first reported platinum(II) complex containing both dppm and dppp ligands. Noticeable features are that the coordination of platinum by the differing dppm and dppp ligands produces a distorted coordination geometry with differing ligand bite angles (and to a lesser extent bond distances), and that the strain induced by the formation of the four-membered dppm chelate ring has a marked effect upon the bond angles at the P atoms of this ligand.